<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-filgrastim.xml</id>
  <title>Recalls Watch: Filgrastim</title>
  <link rel="self" href="https://recalls.watch/feed/substance-filgrastim.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-03-26T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/96325/</id>
    <title>Amgen, Inc.: Neupogen and 1 more</title>
    <link href="https://recalls.watch/recall/fda/96325/"/>
    <updated>2025-03-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96115/</id>
    <title>Teva Pharmaceuticals USA, Inc: Granix</title>
    <link href="https://recalls.watch/recall/fda/96115/"/>
    <updated>2025-02-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit</summary>
  </entry>
</feed>
